| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/18/2011 | US20110201029 Il-13 receptor antibodies |
| 08/18/2011 | US20110200990 RECEPTOR ACTIVATOR OF NF kappa-B |
| 08/18/2011 | US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
| 08/18/2011 | US20110200646 The TRPVL Antagonists SB-795498 For Treating Rhinitis |
| 08/18/2011 | US20110200641 Minor allergen control to increase safety of immunotherapy |
| 08/18/2011 | US20110200637 Immunizing Compositions and Methods of Use |
| 08/18/2011 | US20110200634 Immunogenic formulation |
| 08/18/2011 | US20110200632 Adjuvanting material |
| 08/18/2011 | US20110200631 Lawsonia intracellularis vaccines |
| 08/18/2011 | US20110200629 Tumor antigen peptide and use thereof |
| 08/18/2011 | US20110200628 Chimeric Proteins that Induce Effects Directed Against Viruses |
| 08/18/2011 | US20110200627 Anti-cd147 antibodies, methods and uses |
| 08/18/2011 | US20110200626 Iqgap3 epitope peptides and vaccines containing the same |
| 08/18/2011 | US20110200625 Pharmaceutical composition |
| 08/18/2011 | US20110200617 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 08/18/2011 | US20110200616 Immunizing Compositions and Methods of Use |
| 08/18/2011 | US20110200614 Anthrax specific antibodies |
| 08/18/2011 | US20110200613 Use of B Cell Expansion Agents in Generating Antibodies |
| 08/18/2011 | US20110200608 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| 08/18/2011 | US20110200605 Polypeptides and use thereof |
| 08/18/2011 | US20110200600 Diagnosis and prognosis of immune disorders using stat4 expression |
| 08/18/2011 | US20110200589 Deconvolution method |
| 08/18/2011 | US20110200585 Cd127 binding proteins |
| 08/18/2011 | US20110200584 Method to stimulate immune function and regeneration |
| 08/18/2011 | US20110200579 Novel gene disruptions, compositions and methods relating thereto |
| 08/18/2011 | US20110200557 New 2-amidothiadiazole derivatives |
| 08/18/2011 | CA2789505A1 Free hexasaccharide isolated from several campylobacter species |
| 08/18/2011 | CA2789416A1 Novel uses |
| 08/18/2011 | CA2789174A1 Process for producing an allergen extract |
| 08/18/2011 | CA2788400A1 Antibodies against cxcr4 |
| 08/18/2011 | CA2788284A1 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase |
| 08/18/2011 | CA2787727A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
| 08/18/2011 | CA2786973A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate |
| 08/17/2011 | EP2357200A1 Human antibodies that bind human TNFalpha |
| 08/17/2011 | EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 08/17/2011 | EP2357187A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/17/2011 | EP2357184A1 Imidazoquinoxaline compounds as immunomodulators |
| 08/17/2011 | EP2357179A1 Thiazol-2-yl organic compounds |
| 08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
| 08/17/2011 | EP2356999A1 Compositions to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes |
| 08/17/2011 | EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 08/17/2011 | EP2356992A1 Bifidobactrium for dust mite allergy |
| 08/17/2011 | EP2356914A2 Composition for improving membrane composition and functioning of cells |
| 08/17/2011 | EP2356222A2 Foxp3 natural killer t-cells and the treatment of immune related diseases |
| 08/17/2011 | EP2356151A1 High affinity human antibodies to human il-4 receptor |
| 08/17/2011 | EP2356090A2 Crystalline forms of fingolimod hcl |
| 08/17/2011 | EP2355849A1 Methods of improving the therapeutic efficacy and utility of antibody fragments |
| 08/17/2011 | EP2355828A1 Therapies for hematologic malignancies |
| 08/17/2011 | EP2355797A1 Composition for targeting dendritic cells |
| 08/17/2011 | EP2129216B1 Production of a viable, storable worm egg suspension |
| 08/17/2011 | EP1885717B1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases |
| 08/17/2011 | EP1808170B1 Aqueous eye drops with accelerated intraocular migration |
| 08/17/2011 | EP1781619B1 Sigma receptor inhibitors |
| 08/17/2011 | EP1562571B1 Combination of a diamide derivative and immunosuppressive agents for inhibiting transplant rejection |
| 08/17/2011 | EP1485360B1 Sodium channel blockers |
| 08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 08/17/2011 | EP1404841B1 Cyp1b1 nucleic acids and methods of use |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/17/2011 | CN1942197B Use of Lactic acid bacteria in preparing medicine for improved breast milk |
| 08/17/2011 | CN1899363B Chinese medicine composition for increasing immunity and its preparing method |
| 08/17/2011 | CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses |
| 08/17/2011 | CN102159709A New therapeutic agent for malignant mesothelioma and immunostimulant |
| 08/17/2011 | CN102159574A Tri-cyclic pyrazolopyridine kinase inhibitors |
| 08/17/2011 | CN102159562A Chromene modulators of chemokine receptor activity |
| 08/17/2011 | CN102159546A Aminopyridine kinase inhibitors |
| 08/17/2011 | CN102159543A Novel triazolo(4,3-a)pyridine derivatives, process for preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 08/17/2011 | CN102159241A Tapasin augmentation for enhanced immune response |
| 08/17/2011 | CN102159232A Treatment of inflammatory diseases with mammal beta defensins |
| 08/17/2011 | CN102159231A Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 08/17/2011 | CN102159222A Bioactive agent,pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |
| 08/17/2011 | CN102159201A 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 08/17/2011 | CN102154458A Method for identifying and treating Graves' disease and kit thereof |
| 08/17/2011 | CN102154206A Preparation method of high-purity, high-multiplication capacity and high-cytotoxin activity CIK (cytokine induced kill) cell |
| 08/17/2011 | CN102153622A Immunopotentiator proline-glycocoll cyclic tetrapeptide (C14H20N404) and application |
| 08/17/2011 | CN102153606A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
| 08/17/2011 | CN102153548A Analogue nucleoside derivative containing thiazolidone (thiazinidone) ring, preparation method and application thereof to medicinal preparations |
| 08/17/2011 | CN102153543A Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 08/17/2011 | CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 08/17/2011 | CN102153539A 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 08/17/2011 | CN102153538A Benzocyclodirivative |
| 08/17/2011 | CN102153524A Polymorph of a pharmaceutical |
| 08/17/2011 | CN102153492A Treatment medicament for resisting infectious diseases, and preparation method and application thereof |
| 08/17/2011 | CN102151297A Compound ganoderma lucidum spore soft capsule and preparation method thereof |
| 08/17/2011 | CN102151291A Use of antrodia camphorata for treating diseases |
| 08/17/2011 | CN102151283A Compound medicament for preventing and treating chicken diseases |
| 08/17/2011 | CN102150820A Method for preparing capsorubin and lycopene soft capsules |
| 08/17/2011 | CN101810690B Livestock Chinese medicinal composition for enhancing body immunity and preparation method thereof |
| 08/17/2011 | CN101766713B Anti-allergic traditional Chinese medicine preparation and preparation method thereof |
| 08/17/2011 | CN101703567B Preparation method for traditional Chinese medicine composition for improving immunity of livestock and poultry and use thereof |
| 08/17/2011 | CN101612234B Traditional Chinese medicine processing method |
| 08/17/2011 | CN101511367B Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/17/2011 | CN101375972B Health oral liquid and its preparation |
| 08/16/2011 | US7999109 CCR9 inhibitors and methods of use thereof |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998926 Dimerized T-cell receptor fragment, its compositions and use |
| 08/16/2011 | US7998478 Pharmaceutical composition for treating immune diseases |
| 08/16/2011 | US7998477 Spherical protein particles and methods for making and using them |
| 08/16/2011 | US7998474 Methods for treating an inflammatory disease of the bowel |